Ad is loading...
GCBLX
Price
$36.87
Change
-$0.33 (-0.89%)
Updated
Nov 15 closing price
RAMHX
Price
$35.93
Change
-$0.33 (-0.91%)
Updated
Nov 15 closing price
Ad is loading...

GCBLX vs RAMHX

Header iconGCBLX vs RAMHX Comparison
Open Charts GCBLX vs RAMHXBanner chart's image
Green Century Balanced
Price$36.87
Change-$0.33 (-0.89%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R2E
Price$35.93
Change-$0.33 (-0.91%)
VolumeN/A
CapitalizationN/A
GCBLX vs RAMHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GCBLX vs. RAMHX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCBLX is a StrongBuy and RAMHX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RAMHX has more cash in the bank: 236B vs. GCBLX (408M). RAMHX pays higher dividends than GCBLX: RAMHX (1.84) vs GCBLX (0.44). GCBLX was incepted earlier than RAMHX: GCBLX (33 years) vs RAMHX (10 years). RAMHX is a more actively managed with annual turnover of: 171.00 vs. GCBLX (21.00). RAMHX has a lower initial minimum investment than GCBLX: RAMHX (250) vs GCBLX (2500). RAMHX annual gain was more profitable for investors over the last year : 20.31 vs. GCBLX (14.15). RAMHX return over 5 years is better than : 32.43 vs. GCBLX (25.31).
GCBLXRAMHXGCBLX / RAMHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence33 years10 years-
Gain YTD10.84213.58280%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets408M236B0%
Annual Yield % from dividends0.441.8424%
Returns for 1 year14.1520.3170%
Returns for 3 years-5.169.39-55%
Returns for 5 years25.3132.4378%
Returns for 10 years51.4546.74110%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRVL344.74-1.93
-0.56%
CorVel Corp
FLUT265.45-1.55
-0.58%
Flutter Entertainment plc
INVA18.90-0.34
-1.77%
Innoviva
CMMB1.67-0.06
-3.74%
Chemomab Therapeutics Ltd
MVST0.72-0.06
-7.68%
Microvast Holdings